Patents
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
11/2010
11/18/2010WO2010132758A2 Ospc-based diagnostic test for lyme disease
11/18/2010WO2010132742A1 Methods and compositions for modulating erbb2 activity
11/18/2010WO2010132609A2 Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory
11/18/2010WO2010131946A1 New fungal elicitor protein and its use as resistance marker
11/18/2010WO2010131917A2 Tsp-1, tsp-2, il-17br and hb-egf associated with stem cell activities and applications thereof
11/18/2010WO2010131611A1 Method and device for extracting cedar pollen proteins
11/18/2010WO2010131285A1 Murine model for male infertility obtained by glucocorticoid-induced leucine zipper gene inactivation, method for the preparation and relative uses
11/18/2010WO2010131115A1 Modified fluorescent proteins and methods for using same
11/18/2010WO2010131111A1 Antigen purification process for pertactin antigen
11/18/2010WO2010131097A1 Lipa and its variant useful for biofuel production
11/18/2010WO2010131015A1 Method of labelling interferons with peg
11/18/2010WO2010130985A1 Cmybp-c and mlc2 as diagnostic markers of cardiac injury
11/18/2010WO2010130956A1 Peptides increasing the secretion and/or expression of at least one gastrointestinal mucin and/or inducing an increase in the population of mucus cells or paneth cells
11/18/2010WO2010130810A1 Extracellular yaluronidase from streptomyces koganeiensis
11/18/2010WO2010130030A1 Dna sequences encoding caryophyllaceae and caryophyllaceae-like cyclopeptide precursors and methods of use
11/18/2010WO2010129987A1 Novel receptor hetero-dimers/-oligomers
11/18/2010WO2010111568A3 Plants having altered agronomic characteristics under nitrogen limiting conditions and related constructs and methods involving genes encoding snf2 domain-containing polypeptides
11/18/2010WO2010106441A3 Peptidomimetics for modulating interleukin-1 receptor
11/18/2010WO2010105315A3 Reporter gene constructs for pet
11/18/2010WO2010102085A3 Stabilized reverse transcriptase fusion proteins
11/18/2010WO2010096681A3 Modifications of cupredoxin derived peptides and methods of use thereof
11/18/2010WO2010093928A3 Mutant ros expression in human cancer
11/18/2010WO2010092109A3 Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof
11/18/2010WO2010086277A3 Engineering nf-yb transcription factors for enhanced drought resistance and increased yield in transgenic plants
11/18/2010WO2010081012A3 Disease control with tick phospholipase a2
11/18/2010WO2010057032A3 Self-assembly of protein-based biomaterials with multiple morphologies
11/18/2010WO2010051310A3 ANTI-TNFα FIBRONECTIN TYPE III DOMAIN BASED SCAFFOLD COMPOSITIONS, METHODS AND USES
11/18/2010WO2010046778A3 Novel shigella frotein antigens and methods
11/18/2010WO2010039533A3 Methods for predicting production of activating signals by cross-linked binding proteins
11/18/2010WO2010036979A3 Novel vectors for production of interferon
11/18/2010WO2009151708A3 Peptide analogs of alpha-melanocyte stimulating hormone
11/18/2010WO2009130459A3 Epitopes of il-17a and il-17f and antibodies specific thereto
11/18/2010WO2009126208A8 Heat resistant plants and plant tissues and methods and materials for making and using same
11/18/2010US20100293674 Transgenic plants expressing recombinant barley alanine aminotransferase
11/18/2010US20100293669 Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
11/18/2010US20100293665 Plants With Increased Yield (KO NUE)
11/18/2010US20100293663 Nucleic Acid Molecules and Other Molecules Associated with Plants and Uses Thereof for Plant Improvement
11/18/2010US20100293662 Novel plant homeodomain protein-encoding genes and their uses
11/18/2010US20100293623 Rabbit nuclear cloning method and uses thereof
11/18/2010US20100292453 Lectin compositions and methods for modulating an immune response to an antigen
11/18/2010US20100292447 Method and agent for refolding proteins
11/18/2010US20100292445 Method for Efficient Purification of Bionanocapsule
11/18/2010US20100292444 Novel Prolactin Compounds
11/18/2010US20100292440 Binding Molecules for Human Factor VIII and Factor VIII-Like Proteins
11/18/2010US20100292436 Method for producing bivalirudin
11/18/2010US20100292435 Insulinotropic peptide synthesis using solid and solution phase combination techniques
11/18/2010US20100292434 Igf-1r binding polypeptides and their use
11/18/2010US20100292314 Anti-angiogenic compositions and methods of use
11/18/2010US20100292172 Peptide-Peptidase Inhibitor Conjugates and Methods of Using Same
11/18/2010US20100292171 Competitive Regulation of Hepcidin mRNA by Soluble and Cell-Associated Hemojuvelin
11/18/2010US20100292167 C-met kinase binding proteins
11/18/2010US20100292164 Dimerized peptide
11/18/2010US20100292152 Novel galectin sequences and compositions and methods utilizing same for treating or diagnosing arthritis and other chronic inflammatory diseases
11/18/2010US20100292151 Use of human cytokine receptor
11/18/2010US20100292148 Targeted polylysine dendrimer therapeutic agent
11/18/2010US20100292147 Identification of the hepcidin binding site on ferroportin
11/18/2010US20100292142 Novel neurotrophic factors
11/18/2010US20100292133 Truncated glp-1 derivaties and their therapeutical use
11/18/2010US20100292130 Biological active proteins having increased in vivo and/or in vitro stability
11/18/2010US20100292104 Photoswitchable Method for the Ordered Attachment of Proteins to Surfaces
11/18/2010US20100292091 Mara family helix-turn-helix domains and their methods of use
11/18/2010US20100292083 Providing improved immunoglobulin sequences by mutating cdr and/or fr positions
11/18/2010US20100291680 Methods and compositions for inhibition of membrane fusion-associated events, including hiv transmission
11/18/2010US20100291677 Reducer of immunosuppression by tumor cell and antitumor agent using the same
11/18/2010US20100291629 Use of deleucocytation filters for defensin purification
11/18/2010US20100291628 Cells in which activity of the protein involved in transportation of GDP-fucose is reduced or lost
11/18/2010US20100291616 Novel genes, compositions, kits, and methods for identification, assessment, prevention and therapy of cervical cancer
11/18/2010US20100291612 Peptide Markers for Diagnosis of Preeclampsia
11/18/2010US20100291579 Novel genes encoding proteins having prognostic, diagnostic, preventive, therapeutic, and other uses
11/18/2010US20100291567 Genes and polypeptides relating to hepatocellular or colorectal carcinoma
11/18/2010US20100291556 Isolated aebp1 genomic polynucleotide fragments from chomosome 7 and their uses
11/18/2010US20100291547 Fluorogenic hydrazine-substituted compounds
11/18/2010US20100291219 Methods and compositions relating to progenitor cells
11/18/2010US20100291170 Novel therapies for chronic renal failure
11/18/2010US20100291150 Pseudomonas exotoxin a cd4+ t-cell epitopes
11/18/2010US20100291149 Attenuated listeria spp. and methods for using the same
11/18/2010US20100291147 Recombinant rsv antigens
11/18/2010US20100291141 Truncated l1 protein of human papillomavirus type 11
11/18/2010US20100291139 Recombinant mva virus and the use thereof
11/18/2010US20100291138 Vaccine
11/18/2010US20100291137 Method for refolding neisserial nspa protein
11/18/2010US20100291134 Truncated hepatitis c virus ns5 domain and fusion proteins comprising same
11/18/2010US20100291133 Recombinant protein containing a c-terminal fragment of plasmodium msp-1
11/18/2010US20100291132 Streptococcus uberis adhesion molecule
11/18/2010US20100291131 Clostridial toxin netb
11/18/2010US20100291130 Cloned genome of infectious hepatitis c virus strain hc-tn and uses thereof
11/18/2010US20100291127 Tumor associated antigen peptides and use of same as anti-tumor vaccines
11/18/2010US20100291126 Protein showing enhanced expression in cancer cells
11/18/2010US20100291125 Eta-1 gene and methods for use
11/18/2010US20100291124 Extracellular serine protease
11/18/2010US20100291122 Method for enhancing immune response with peptide
11/18/2010US20100291121 Tumour-Specific Animal Proteins
11/18/2010US20100291120 Peptides regulating the surface expression of the t cell receptor
11/18/2010US20100291119 Alpha B crystallin for use in diagnosis and therapy of auto-immune diseases in particular multiple sclerosis
11/18/2010US20100291118 Class of Gamma Delta T Cells Activators and Use Thereof
11/18/2010US20100291109 Tlr agonist (flagellin)/cd40 agonist/antigen protein and dna conjugates and use thereof for inducing synergistic enhancement in immunity
11/18/2010US20100291105 Agent for the treatment of malignant diseases
11/18/2010US20100291104 Bordetella outer-membrane protein antigens and methods of making and using the same
11/18/2010US20100291099 Novel 27411, 23413, 22438, 23553, 25278, 26212, narc sc1, narc 10a, narc 1, narc 12, narc 13, narc17, narc 25, narc 3, narc 4, narc 7, narc 8, narc 11, narc 14a, narc 15, narc 16, narc 19, narc 20, narc 26, narc 27, narc 28, narc 30, narc 5, narc 6, narc 9, narc 10c, narc 8b, narc 9, narc2a, narc 16b, narc 1c, narc 1a, narc 25, 86604 and 32222 molecules and uses therefor
11/18/2010US20100291096 Therapeutic peptides for the treatment of metatstatic cancer